MarketPeel
Insider Trading Intelligence
RM

Ross Muken

SOPH
PRESIDENT · SOPHIA GENETICS SA · CIK 0002005463
FILING MIX · LIFETIME25%/75%
BUYS
4
SELLS
12
TOTAL VALUE
$166.2K
COMPANIES
1
ACTIVE SINCE
Mar 2026
HOLDINGS NOW
670,651
AVG SELL PX
$4.94
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 28 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Ross Muken, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+33.33%+2.81%+2.68%+0.14%+0.78%
14d9+0.00%+3.08%+4.03%-0.95%-1.68%
30d9+33.33%+1.36%+8.93%-6.32%-5.02%
60d9+28.57%+1.24%+9.48%-8.48%-10.23%
90d9(1 pending)+0.00%+11.24%+11.16%+0.08%+1.99%
180d9(9 pending)
1y9(9 pending)
2y9(9 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SOPH · 670,651 shares · as of Jul 6, 2026
0175,780351,561527,341703,121SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
2026
FLOW · 4 buys / 12 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
9,838$5.22$51.4K670,651Jul 6, 2026Jul 7, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
422$5.38$2.3K680,489Jun 22, 2026Jun 23, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
761$4.60$3.5K680,911May 19, 2026May 20, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
760$5.20$4.0K681,672Apr 20, 2026Apr 21, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,800$4.96$13.9K682,432Apr 14, 2026Apr 16, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
4,442$4.77$21.2K685,232Apr 13, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
3,687$4.69$17.3K689,674Apr 10, 2026Apr 14, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,950$4.74$9.2K693,361Apr 9, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,786$4.84$13.5K695,311Apr 8, 2026Apr 10, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,424$4.87$11.8K698,097Apr 7, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
2,600$4.85$12.6K700,521Apr 6, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
628,743628,743Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
431,211431,211Apr 2, 2026Apr 3, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
431,211703,121Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
PURCHASEGRANT
Stock grant
628,743628,743Apr 2, 2026Apr 8, 2026View →
SOPH
SOPHIA GENETICS SA
SALE10b5-1
10b5-1 plan
1,183$4.79$5.7K271,910Mar 19, 2026Mar 20, 2026View →
Other insiders · SOPH
Loading peer insiders…
About this filer
CIK 0002005463
ROLE
President
PRIMARY
SOPH
COMPANIES
1
ACTIVE SINCE
Mar 2026
MARKETPEEL · /INSIDER/0002005463DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback